product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Ran Antibody
catalog :
4462
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot
citations: 2
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; fig 1
Dettmer U, Newman A, Soldner F, Luth E, Kim N, von Saucken V, et al. Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun. 2015;6:7314 pubmed publisher
Newman A, Selkoe D, Dettmer U. A new method for quantitative immunoblotting of endogenous ?-synuclein. PLoS ONE. 2013;8:e81314 pubmed publisher
product information
SKU :
4462S
Product-Name :
Ran Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Hm, Mk, B, (Dm, X)
Applications :
Western blot
Product-Category :
Cytoskeletal Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
24
Host :
Rabbit
Target :
Ran
Primary-Protein :
RAN
Alt-Names :
ARA24,Androgen receptor-associated protein 24,GTP-binding nuclear protein Ran,GTPase Ran,Gsp1,OK/SW-cl.81,RAN,RAN, member RAS oncogene family,RanGTPase,Ras-like protein TC4,Ras-related nuclear protein,TC4,guanosine triphosphatase Ran,member RAS oncogene family
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.